Aevex Corp.

The stock is still in a long downtrend after a sharp post-IPO reset, trading well below its 200-day average and far under the 52-week high. The setup is more of a damaged recovery than a confirmed reversal, with price now working above the 52-week low but still in a fragile multi-month range.

Street sentiment is constructive, with a Buy consensus and an average target of 28.22 versus a recent close near 11.6. Recent action has been mixed but supportive: multiple firms initiated at Outperform/Buy, while target cuts from RBC and Piper Sandler show expectations have been trimmed.

The company has beaten estimates in both reported quarters, including a 16.7% EPS beat in August and an 11.8% beat in May. Next quarter expectations are modest at 0.09 EPS, so shareholders should watch whether revenue momentum and margin discipline can keep the beat streak intact.

The pattern is net selling, driven by large June dispositions from a 10 percent owner and a director. The May awards to directors and executives look like compensation-related grants, not a bullish signal; the meaningful read is that ownership has been reduced rather than accumulated.

Profitability is positive but still uneven: gross margin is 25.4%, operating margin is 10.21%, and net margin is 6.53%. Growth is the main support, with revenue up 99.5% year over year, but free cash flow was negative $89.2 million in fiscal 2025 and ROE remained negative at -7.17%.

AVEX sits in aerospace and defense with a defense-technology niche around UAS, ISR, and mission systems. The valuation still screens rich at 55.24x earnings, above what the current margin and cash-flow profile would usually justify, even with analyst targets implying meaningful upside.